Mon, March 30, 2020

Christopher Marai Maintained (VYGR) at Strong Buy with Decreased Target to $16 on, Mar 30th, 2020

Christopher Marai of Nomura, Maintained "Voyager Therapeutics, Inc." (VYGR) at Strong Buy with Decreased Target from $37 to $16 on, Mar 30th, 2020.

Christopher has made no other calls on VYGR in the last 4 months.



There are 4 other peers that have a rating on VYGR. Out of the 4 peers that are also analyzing VYGR, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $14 on, Wednesday, March 4th, 2020


These are the ratings of the 3 analyists that currently disagree with Christopher


  • Aydin Huseynov of "Benchmark" Initiated at Strong Buy and Held Target at $18 on, Thursday, March 19th, 2020
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $27 on, Wednesday, March 4th, 2020
  • Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $26 on, Thursday, February 6th, 2020